University of Arizona researchers devised a new method to deliver cancer chemotherapy drugs to pancreatic and breast cancer ...

A new formulation of the drug paclitaxel may help overcome some common limitations of chemotherapy drugs, setting the stage ...

综述：细胞焦亡（Pyroptosis）与紫杉醇（Paclitaxel）在抗肿瘤作用中的治疗联系：最新综述 《Naunyn-Schmiedeberg's Archives of Pharmacology》：Therapeutic connections between pyroptosis and paclitaxel in anti-tumor effects: an updated review ...

University of Arizona researchers devised a new method to deliver cancer chemotherapy drugs to pancreatic and breast cancer tumors more effectively and with less damage to healthy tissues than ...

Novocure (NASDAQ: NVCR) today announced it submitted a premarket approval (PMA) application to the U.S. Food and Drug Administration (FDA) for Tumor Treating Fields (TTFields) therapy for the ...

Background: Gynecologic carcinosarcomas (CS) are rare yet aggressive epithelial malignancies for which optimal therapy is debated. PI was shown to be superior to I. PC demonstrated compelling phase 2 ...

Paclitaxel Medication Information Learn everything you need to know about Paclitaxel-pronunciation, uses, dosage guidelines, indications, and when to take or avoid it. Get up-to-date information ...

Conclusions: BBI608 plus weekly paclitaxel has demonstrated safety, tolerability, and promising activity in patients with refractory, heavily pretreated pancreatic cancer; particularly in taxane-naïve ...

The addition of carboplatin to paclitaxel improved pathologic complete response and EFS with no increase in secondary malignancies among patients with triple-negative breast cancer, randomized ...

In this press release, forward-looking statements include statements concerning: our ROSELLA trial and the potential of relacorilant combined with nab-paclitaxel to benefit patients; our BELLA ...